CPRIT CCPF
About Us
Gulf Coast Consortia (GCC) Center for Comprehensive PK/PD & Formulation (CCPF) provides pre-clinical drug development services from formulation development to PK/PD characterization, including wide variety of in vitro, in situ and in vivo studies in 9 specific areas: drug characterization, basic formulation, advanced drug delivery, bioanalysis, in vitro metabolism, in vitro biopharma characterization, in vivo PK, in vitro/in vivo PD and PK/P modeling and simulation. In the past eight (8) years, we have provided over 300 project services for various Texas investigators and supported their grant applications, IND filings, and product commercialization.
Our Development Process
Leadership
Dong Liang, Ph.D.
Professor and Chair, Department of Pharmaceutical and Environmental Health Sciences, TSU COPHS.
Huan Xie
Professor of Pharmaceutics and Director of NIH-RCMI Pharmacology Core, TSU COPHS. Dr. Xie has a broad background in nano-formulation and targeted drug delivery, with specific expertise in cancer therapy applications.
Diana S-L. Chow, Ph.D.
Professor of Pharmaceutics and Director of the Institute for Drug Education and Research (IDER) at UHCOP, and Fellow of the National Academy of Inventors.